SCHEMBL21667306

SCHEMBL21667306

CC(C)n1c(=O)cc(NCc2cccc(Cl)c2)[nH]c1=O

nearest known ligand 0.50

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ CYP3A4 P08684 1/20 0.50
▸ CYP2B6 P20813 1/20 0.50
▸ PDE9A O76083 2/20 0.49
▸ PGR P06401 1/20 0.45
▸ GPR84 Q9NQS5 1/20 0.44
▸ FABP4 P15090 1/20 0.42
▸ LMNA P02545 2/20 0.42
▸ MAPT P10636 1/20 0.42
▸ MEN1 O00255 1/20 0.42
▸ KMT2A Q03164 1/20 0.42
▸ TP53 P04637 1/20 0.41
▸ SMN1; SMN2 Q16637 1/20 0.41
▸ POLB P06746 1/20 0.41
▸ PDE2A O00408 1/20 0.41
▸ PIK3CA P42336 1/20 0.40
▸ PIK3CB P42338 1/20 0.40
▸ ALDH1A1 P00352 1/20 0.40
▸ L3MBTL1 Q9Y468 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21667347 0.88 CYP3A4 (0.50) CYP3A4CYP2B6PDE9ALMNAMEN1
SCHEMBL20716038 0.87 CYP3A4 (0.61) CYP3A4CYP2B6PDE9AGPR84LMNA
SCHEMBL21667374 0.86 CYP3A4 (0.52) CYP3A4CYP2B6PDE9AGPR84LMNA
SCHEMBL21667176 0.86 CYP3A4 (0.49) CYP3A4CYP2B6PGRGPR84LMNA
SCHEMBL21667309 0.86 CYP3A4 (0.49) CYP3A4CYP2B6PDE9AGPR84LMNA
SCHEMBL21667252 0.84 PDE9A (0.50) CYP3A4CYP2B6PDE9AMAPTMEN1
SCHEMBL21667387 0.82 PGR (0.47) PDE9APGRGPR84FABP4LMNA
SCHEMBL21667270 0.81 KMT2A (0.64) CYP3A4CYP2B6PDE9AMAPTMEN1
SCHEMBL21667382 0.80 ADORA1 (0.49) PDE9APGRGPR84FABP4MEN1
SCHEMBL21667332 0.80 CYP3A4 (0.49) CYP3A4CYP2B6PGRGPR84LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3010910-B1 PYRIMIDINEDIONE COMPOUNDS AGAINST CARDIAC CONDITIONS MYOKARDIA INC (US) 2020-02-05 — — EP disclosed
Send feedback